Table S2.
The achievement rate of treatment goals (for BP, LDL-C, and both BP and LDL-C) stratified by each dose of Rovelito®
| Control rate (%) | Each dose of Rovelito (Irbesartan/Atorvastatin in mg, N=931) | P-valuea | |||
|---|---|---|---|---|---|
| 150/10 (n=722) | 150/20 (n=145) | 300/10 (n=54) | 300/20 (n=10) | ||
| BP alone | 86.01% (n=621) | 86.21% (n=125) | 87.04% (n=47) | 80.00% (n=8) | 0.9499 |
| LDL-C alone | 85.87% (n=620) | 84.14% (n=122) | 87.04% (n=47) | 80.00% (n=8) | 0.8872 |
| Both BP and LDL-C | 74.93% (n=541) | 71.72% (n=104) | 77.88% (n=42) | 70.00% (n=7) | 0.7841 |
Note:
a
Chi-squared test or Fisher’s exact test.
Abbreviations: BP, blood pressure; LDL-C, low-density lipoprotein-cholesterol.